Neurosurgeons From Around The World Gather At PLA 301 Hospital In China
Main Category: Neurology / NeuroscienceAlso Included In: MRI / PET / Ultrasound; Conferences
Article Date: 09 Apr 2009 - 1:00 PDT
IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") participated in China's first international conference on intra-operative MR held at PLA 301 Hospital in Beijing on April 5, 2009. Over 300 neurosurgeons from China, USA, Germany, Taiwan and Hong Kong attended the inaugural event that focused on developments in intra-operative MR for neurosurgery. The conference was opened by Dir Chen Xiaohong, Director of PLA 301, and featured scientific presentations from Peter Black, Professor of Neurosurgery, Harvard Medical School, Christopher Nimsky, Professor and Chairman of Neurosurgery, University Marburg, and Michael Buchfelder, Professor and Chairman of Neurosurgery, University of Erlangen.
The conference program included the official opening of PLA 301's IMRISneuro suite - the first-of-its-kind surgical OR with integrated intra-operative MR imaging in China. Featuring a 1.5 Tesla wide bore magnet, IMRISneuro provides the hospital's surgical team with high quality images before, during and after procedures without moving the patient. Over 150 of the conference delegates were able to observe portions of a live case tumor resection using the new system.
PLA 301's neurosurgical team completed its first procedure on February 23, 2009, and completed five procedures in the first week of operation. In the six weeks since installation of the IMRISneuro suite, the team treated 43 patients suffering with glioma or epilepsy. While PLA 301 is widely-recognized for performing at the highest of global clinical standards, Dr. Xu Bainan, Chairman of Neurosurgery, said: "IMRIS has significantly advanced our neurosurgical capabilities and the system is contributing directly to our hospital's reputation as a world-class facility."
At the conference, David Graves, President and CEO of IMRIS shared his excitement about the project. "It is an honor to have been chosen by the neurosurgical team at PLA 301", said Mr. Graves. "We are certain this technology in their hands will help continue to provide the highest quality of care for their patients."
About IMRIS
IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical imaging solutions. The company's flagship product, IMRISneuro, utilizes patented technology that allows a high field MRI scanner to be moved in to the operating room on demand, providing imaging during the surgical procedure without compromising patient safety. This unique and innovative system has been validated by leading neurosurgeons for use in world-class neuroscience centers
Source: IMRIS Inc.
Visit our neurology / neuroscience section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/145685.php>
APA
http://www.medicalnewstoday.com/releases/145685.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (2)
Suffering with occipital meningioma
posted by surinder Kaur on 21 Jul 2010 at 5:28 amDiagnosis was Occipital Meningioma HPR S-10110106 ANAPLASTIC . SHE WAS OPERATED ON 06 SEP. 2006 BY A NEUROSURGEON AT PGI CHANDIGARH. Left occipital craniotomy and near lobe excision of tumor.
Now again suffering with same problem and growth has occured again. Kindly suggest what should we do?
Occipital Meningioma HPR S-10110106 ANAPLASTIC
posted by surinder kaur on 22 Jul 2010 at 1:03 amDiagnosis was Occipital Meningioma HPR S-10110106 ANAPLASTIC . SHE WAS OPERATED ON 06 SEP. 2006 BY A NEUROSURGEON AT PGI CHANDIGARH. Left occipital craniotomy and near lobe excision of tumor.
Now again suffering with same problem and growth has occured again. Kindly suggest what should we do?
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




